Cardiome Pharma Corporation (CRME)
Your Dashboard
Displaying CRME Charts
Personalize your Dashboard. You can add and remove charts, drag and drop them into the order you
like, and we'll save your settings for the next time you visit when you're logged in.
Log in here or Click here to register for your free account.
Select or add more charts
- Accounts Payable 0.35M
- Accounts Receivable 1.24M
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization 0.0232
- Beneish M-Score Pro
- Beta Pro
- Book Value 25.28M
- Book Value per Share 0.4135
- Capital Expenditures 0.00
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing 0.00
- Cash Financing TTM 0.35M
- Cash Investing -0.07M
- Cash Investing TTM -1.01M
- Cash Operations -5.90M
- Cash Operations TTM -27.60M
- Cash and Equivalents 48.64M
- Cash and ST Investments 48.64M
- Current Ratio 15.31
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio 0.9889
- Dividend
- Dividend Yield 0.00%
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share -0.10
- Earnings Per Share Growth
- Earnings Per Share TTM -0.47
- Earnings Yield -106.8%
- Effective Tax Rate TTM Pro
- Enterprise Value 3.257M
- Expenses 6.32M
- Expenses TTM 29.42M
- Free Cash Flow -5.94M
- Free Cash Flow TTM -28.27M
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM 1.50M
- Income from Cont. Ops Pro
- Interest Expense 0.00
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities 28.30M
- Long Term Debt 0.00
- Market Cap 26.90M
- Net Income -5.92M
- Net Income TTM -27.92M
- Net PP&E 1.96M
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price 0.44
- Price / Book Value 1.064
- Price / Sales Ratio 17.93
- Price / Tangible Book Value Pro
- Profit Margin -1480%
- R&D Expense 3.45M
- Receivables Turnover 1.586
- Retained Earnings -287.20M
- Retained Earnings Growth
- Return on Assets -41.26%
- Return on Equity -73.78%
- Return on Invested Capital Pro
- Revenue Growth 33.33%
- Revenue Per Share TTM 0.0245
- Revenues 0.40M
- Revenues TTM 1.50M
- SG&A Expense 2.10M
- Shareholders Equity 25.28M
- Shares Outstanding 61.13M
- Stock Buybacks 0.00
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets 54.03M
- Total Return Price 0.44
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
What do these terms mean? Read all about them in the Glossary.
You may also be interested in these CRME related companies
CRME News
This company is amazing! A brick is more creative, eloquent and energetic than this $CRME management.
about 10 days ago by OysterX
about 10 days ago by OysterX
Very Interesting One : $CRME ( 0.70 ) This One Will Head Back Over a Buck ! Add On Your Watchlist And Keep An Eye On It ...
about 58 days ago by WallStreetBeats
about 58 days ago by WallStreetBeats
@PIER $CRME I have a feeling it may take a while. could test new lows, though the market hasn't helped.. but its a good buy here
about 60 days ago by peoples
about 60 days ago by peoples
$CRME With Merck calling it quits, is there a possibility that another big player might swoop in? Just wondering.
about 66 days ago by MarketBuy
about 66 days ago by MarketBuy
$CRME Long at .785. Let's go. Merck pullout just a minor setback. PPS is lower than book or cash per share! Easy long!
about 66 days ago by MarketBuy
about 66 days ago by MarketBuy
$CRME they have the cash on hand and it is equal or even more than share price.. its an easy buy
about 68 days ago by peoples
about 68 days ago by peoples
$CRME master at catching a falling knife... and it is not yet... but coming
about 70 days ago by peoples
about 70 days ago by peoples
$CRME I'll let you guys know when to buy.. it is starting to look interesting... sorry for those who thought they are getting in right
about 70 days ago by peoples
about 70 days ago by peoples
Oppenheimer Downgrades Cardiome Pharmaoration from Outperform to Perform, Removes PT from $ to $
Mar 19, 2:25PM Benzinga
Mar 19, 2:25PM Benzinga
$CRME Funny, this morning's plungle probably caused a few heart attacks. Ironic? A little.
about 70 days ago by MarketBuy
about 70 days ago by MarketBuy
Cardiome Announces Positive Phase 1 PK/PD Trial Results for Vernakalant Oral
Nov 03, 5:09PM GlobeNewswire
Nov 03, 5:09PM GlobeNewswire
Cardiome should benefit from significant vernakalant progress, says Oppenheimer
Sep 12, 7:28AM FlyOnTheWall
Sep 12, 7:28AM FlyOnTheWall
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CRME | 0.44 | +0.01 | +2.33% | 26.90M |
| CRMD | 0.27 | -0.01 | -3.50% | 3.081M |
| CRM | 147.00 | +0.79 | +0.54% | 20.14B |
| CRL | 33.56 | +0.21 | +0.63% | 1.641B |
| CPA | 83.85 | +0.62 | +0.74% | 3.713B |
| CP | 74.95 | -0.57 | -0.75% | 12.81B |
| COY | 7.40 | -0.04 | -0.54% | |
| COWN | 2.39 | +0.00 | +0.00% | |
| COVR | 1.54 | +0.00 | +0.00% | 39.42M |
| COV | 53.32 | -0.14 | -0.26% | 25.77B |
